Oarsman Capital’s Neogen NEOG Stock Holding History

Oarsman Capital’s Portfolio NEOG Stock Details NEOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,073	Closed	-$13K	–	623
2024 Q4	$13K	Buy	1,073 +62	+6%	+$867	﹤0.01%	660
2024 Q3	$17K	Buy	+1,011	New	+$16.6K	﹤0.01%	624

Other funds holding NEOG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

GCM

Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Oarsman Capital's NEOG Position: Q1 2025 in Review

Oarsman Capital sold out of Neogen (NEOG) in Q1 2025, closing a stake of 1,073 shares — an estimated $13K sold.

Oarsman Capital first reported a position in NEOG in Q3 2024 and held it in 2 quarters. The position peaked at $17K in Q3 2024. 339 funds tracked by Wall St. Rank hold NEOG as of Q1 2025.

Oarsman Capital reported no remaining Neogen position as of Q1 2025 after selling out during the quarter.
Oarsman Capital sold 1,073 Neogen shares in Q1 2025, an estimated $13K.
Oarsman Capital first reported a position in Neogen in Q3 2024 and held it in 2 quarters.
Oarsman Capital's Neogen position peaked at $17K in Q3 2024.
339 funds tracked by Wall St. Rank held Neogen as of Q1 2025.

Based on Oarsman Capital's 13F filing for Q1 2025, filed 14 May 2025.